%20(1).png)
Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Australia: Listed as a Schedule 4 prescription-only medicine
While the peptides lack of IGF-1 effects and glucose impact suggests minimal interaction potential, comprehensive medication review remains appropriate, particularly for drugs affecting metabolism or blood glucose
Some centres may offer holotranscobalamin (active B12) testing as an alternative
Hypokalemia: In extremely rare cases, B12 injections may lead to low potassium levels in the blood, known as hypokalemia
AOD-9604 received FDA Investigational New Drug status for obesity trials in the early 2000s but was never approved
US$ 22.91
US$ 26.17
US$ 28.69
US$ 25.04
US$ 22.49
US$ 22.14
US$ 23.68
US$ 27.98
US$ 28.94
US$ 23.39
